ArticleBlood cancer discovery2023

Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.

Ruth Flümann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.